News

Swiss Deep Tech News & Analysis

Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.

DTN Highlights

  • Aseptuva, Bloom and Hafnova secure grants in multi-year European projects

    Three startups—each offering pioneering solutions to tackle hospital-acquired infections, biomass deconstruction, and cybersecurity—have been selected to participate in leading European projects. The inclusion of Swiss…

    startupticker.ch

    • Aseptuva's UVC device reduces hospital-acquired infections affecting 9M European patients by automating contamination-prone catheter management procedures.
    • Bloom Biorenewables joins €9M Wood2Wood project to transform contaminated wood waste into sustainable chemicals, addressing Europe's 2030 wood shortage.
    • Hafnova accesses EuroHPC supercomputers to scale AI models for detecting DNS-level cyber threats, emphasizing Swiss digital sovereignty and data protection.
    startupticker.ch: Aseptuva, Bloom and Hafnova secure grants in multi-year European projects
  • GlycoEra AG raises $130 Million to advance therapies for autoimmune diseases

    GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders for the treatment of autoimmune diseases, closed an oversubscribed $130 million Series B financing. The…

    startupticker.ch

    • GlycoEra raised $130M Series B led by Novo Holdings to advance its IgG4 protein degrader into clinical trials this year.
    • GlycoEra's lead program GE8820 selectively degrades pathogenic IgG4 autoantibodies in pemphigus, myasthenia gravis, and other autoimmune diseases.
    startupticker.ch: GlycoEra AG raises $130 Million to advance therapies for autoimmune diseases
  • Hedera Dx raises €15M to bring modern cancer care to patients worldwide

    Hedera Dx, the European techbio company headquartered in Switzerland, just announced the closing of a €15 million Series A financing round to drive advanced cancer…

    startupticker.ch

    • Hedera Dx raised €15M Series A to expand blood-based cancer testing across European hospital labs outside U.S.
    • The company's liquid biopsy platform enables cost-efficient, in-house cancer diagnostics across 11 European countries.
    • Hedera Dx combines molecular profiling with AI analytics to support precision oncology and drug development decisions.
    startupticker.ch: Hedera Dx raises €15M to bring modern cancer care to patients worldwide
  • Promising Swiss innovations unveiled at VivaTech 2025

    The 9th edition of Viva Technology, Europe’s largest startup conference, takes place on June 11-14, 2025, with a strong Swiss delegation comprising 31 technology startups…

    startupticker.ch

    • VivaTech 2025 in Paris hosts 31 Swiss startups at the Swiss Pavilion, with two selected for the Top 100 most promising European startups.
    • Swiss startups at VivaTech span healthtech, AI, renewable energy, and autonomous vehicles, including organ-on-chip and Level 4 delivery tech.
    • The Swiss Pavilion is organized by Presence Switzerland, Switzerland's Embassy in France, and supported by Switzerland Global Enterprise.
    startupticker.ch: Promising Swiss innovations unveiled at VivaTech 2025
  • Gates Foundation awards $5 million grant to Axmed

    As part of the global health movement to expand affordable access to high-quality medicines, the Gates Foundation has awarded a $5 million grant to Axmed,…

    startupticker.ch

    • Gates Foundation awarded Axmed $5M matching funds to boost government procurement of maternal, newborn, and child health commodities in Sub-Saharan Africa.
    • Axmed's platform achieved 20-30% average medicine savings, with some MNCH products reducing costs by up to 80% through aggregated demand.
    • The grant unlocks $10M in MNCH procurement while addressing 287,000 maternal deaths and 2.3M preventable newborn deaths annually.
    startupticker.ch: Gates Foundation awards $5 million grant to Axmed
  • Etops acquires Finanzportal24

    Finanzportal24, a leading provider of financial planning software in Germany, becomes part of Zug-based Etops. With the acquisition, Etops strengthens its position in the market…

    startupticker.ch

    • Etops acquires Finanzportal24, a German financial planning software with 4,500+ users, to expand its WealthTech platform in Europe.
    • Finanzportal24 operates independently while accessing Etops's market reach, infrastructure, and network for growth.
    • The acquisition advances Etops's buy-and-build strategy to build a leading European WealthTech platform for banks, advisors, and insurers.
    startupticker.ch: Etops acquires Finanzportal24
  • Timeline secures USD 250k at XPRIZE Healthspan competition

    Swiss longevity start-up Timeline has been named a Milestone 1 Award Winner in the prestigious XPRIZE Healthspan competition. Selected from hundreds of international teams, Timeline…

    startupticker.ch

    • The $101M XPRIZE competition awards $81M to the grand prize winner in 2030, with clinical trials from 2026-2029 testing therapies on adults aged 50-80.
    startupticker.ch: Timeline secures USD 250k at XPRIZE Healthspan competition
  • CSEM spins out foundry manufacturing photonic integrated circuits

    CCRAFT is a production-ready pure-play foundry offering chips based on Thin-Film Lithium Niobate technology, one of the fastest growing platforms in photonics. Incorporated in April…

    startupticker.ch

    • CCRAFT is the first production-ready foundry for Thin-Film Lithium Niobate photonic chips, offering 8x faster speed and 10x lower energy use.
    • The company plans to expand Neuchâtel production to deliver 12 million chips annually by 2030, targeting 30% global photonic chip market share.
    • TFLN technology enables quantum technologies, advanced sensing, lidar, and space systems with low optical losses and wide transparency ranges.
    startupticker.ch: CSEM spins out foundry manufacturing photonic integrated circuits
  • CHF 6 million to bring pre-IPO investment opportunities to blockchain

    Geneva-based Colb Asset SA, focussed on real-world asset tokenization, has closed an oversubscribed CHF 6 million seed extension round. The investment comes from a private…

    startupticker.ch

    • Colb Asset SA raised CHF 6 million in an oversubscribed seed extension from a major $20+ billion asset manager.
    • Funding accelerates blockchain tokenization of pre-IPO equity, wealth strategies, and investment funds for global access.
    • Colb tokenizes energy, infrastructure, utilities, and agribusiness assets to democratize institutional-grade investments worldwide.
    startupticker.ch: CHF 6 million to bring pre-IPO investment opportunities to blockchain
  • Multi-year deals for four cleantech startups

    Companies that collaborate with startups and implement their solutions play a vital role in helping these young businesses scale and reach broader markets. Recent multi-year…

    startupticker.ch

    • Terralayr's virtual battery deal with Vattenfall lets smaller decentralized systems access large-scale agreements, expanding storage financing in Germany.
    • Voltiris and AIKO Energy deploy spectral-filtering solar in Chinese greenhouses for simultaneous crop and clean energy production.
    • Climeworks signed its first Japanese carbon removal contract with NYK shipping, providing CO₂ removal solutions through 2028.
    startupticker.ch: Multi-year deals for four cleantech startups
  • HAYA Therapeutics banks $65 million Series A funding

    Led by Sofinnova Partners and Earlybird Venture Capital, Haya Therapeutics’ Series A funding round also involved a syndicate of investors, including Eli Lilly and Company.…

    startupticker.ch

    • HAYA Therapeutics raised $65M Series A funding led by Sofinnova and Earlybird for HTX-001, an lncRNA therapy targeting heart failure.
    • HAYA's platform targets the regulatory genome to reprogram disease-driving cell states rather than just manage symptoms.
    • HAYA plans to expand into pulmonary fibrosis, obesity, and age-related diseases using its proprietary genome-mapping technology.
    startupticker.ch: HAYA Therapeutics banks $65 million Series A funding
  • Digital exchange SDX attracts Citi as partner

    Expected to be live by the third quarter of 2025, leading global bank Citi and SDX, part of SIX Group, are developing a scalable solution…

    startupticker.ch

    • Citi and SDX launch tokenized platform for pre-IPO shares in Q3 2025, improving institutional investor access to private companies.
    • SDX's regulated blockchain Central Securities Depository simplifies liquidity management and cap table control for high-growth private firms.
    • Sygnum and SBI Digital Markets will distribute pre-IPO equities to clients across Europe and Asia.
    startupticker.ch: Digital exchange SDX attracts Citi as partner